Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

0A4J

Astrazeneca (0A4J)

Astrazeneca Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0A4J
DateTimeSourceHeadlineSymbolCompany
01/02/202410:00AMUK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
12/27/20232:00AMUK RegulatoryAstraZeneca PLC AstraZeneca acquires GracellLSE:0A4JAstrazeneca Plc
12/22/20232:00AMUK RegulatoryAstraZeneca PLC Wainua (eplontersen) granted first US FDA approvalLSE:0A4JAstrazeneca Plc
12/14/202310:00AMUK RegulatoryAstraZeneca PLC Director/PDMR ShareholdingLSE:0A4JAstrazeneca Plc
12/12/20232:05AMUK RegulatoryAstraZeneca PLC AstraZeneca to acquire IcosavaxLSE:0A4JAstrazeneca Plc
12/01/202310:05AMUK RegulatoryAstraZeneca PLC Block listing Interim ReviewLSE:0A4JAstrazeneca Plc
12/01/202310:00AMUK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
12/01/20232:00AMUK RegulatoryAstraZeneca PLC Discontinuation of two CRYSTALIZE evidence trialsLSE:0A4JAstrazeneca Plc
11/23/202310:00AMUK RegulatoryAstraZeneca PLC Director/PDMR ShareholdingLSE:0A4JAstrazeneca Plc
11/17/20232:00AMUK RegulatoryAstraZeneca PLC Truqap approved in US for HR+ breast cancerLSE:0A4JAstrazeneca Plc
11/14/20232:05AMUK RegulatoryAstraZeneca PLC Update on PACIFIC-2 Phase III trial for ImfinziLSE:0A4JAstrazeneca Plc
11/09/202310:00AMUK RegulatoryAstraZeneca PLC Director DeclarationLSE:0A4JAstrazeneca Plc
11/09/20232:10AMUK RegulatoryAstraZeneca PLC Imfinzi combination improves PFS in liver cancerLSE:0A4JAstrazeneca Plc
11/09/20232:05AMUK RegulatoryAstraZeneca PLC Agreement with Eccogene for clinical stage GLP-1RALSE:0A4JAstrazeneca Plc
11/09/20232:00AMUK RegulatoryAstraZeneca PLC 9M and Q3 2023 resultsLSE:0A4JAstrazeneca Plc
11/01/202311:00AMUK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
11/01/20233:00AMUK RegulatoryAstraZeneca PLC AstraZeneca cell & gene therapy deal w/ CellectisLSE:0A4JAstrazeneca Plc
10/03/20232:00AMUK RegulatoryAstraZeneca PLC AstraZeneca settles Nexium liability litigationsLSE:0A4JAstrazeneca Plc
10/02/202310:00AMUK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
09/22/20232:00AMUK RegulatoryAstraZeneca PLC Dato-DXd improved PFS in breast cancerLSE:0A4JAstrazeneca Plc
09/20/20232:00AMUK RegulatoryAstraZeneca PLC Alexion completes Pfizer gene therapy agreementLSE:0A4JAstrazeneca Plc
09/15/202310:00AMUK RegulatoryAstraZeneca PLC Enhertu recommended in EU for HER2-mutant NSCLCLSE:0A4JAstrazeneca Plc
09/11/202311:00AMUK RegulatoryAstraZeneca PLC Fasenra Phase III EGPA trial met primary endpointLSE:0A4JAstrazeneca Plc
09/06/20232:00AMUK RegulatoryAstraZeneca PLC Update on US review of Ultomiris for NMOSDLSE:0A4JAstrazeneca Plc
09/01/202310:00AMUK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
08/01/202310:00AMUK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
07/28/20232:05AMUK RegulatoryAstraZeneca PLC Alexion enters gene therapy agreement with PfizerLSE:0A4JAstrazeneca Plc
07/28/20232:00AMUK RegulatoryAstraZeneca PLC Half-year ReportLSE:0A4JAstrazeneca Plc
07/17/20231:10PMUK RegulatoryAstraZeneca PLC Beyfortus approved in US for infant RSV preventionLSE:0A4JAstrazeneca Plc
07/03/202310:00AMUK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:0A4J